Pharmaceutical Industry Blog

Last Updated: June 17, 2026 TL;DR: Caffeine Citrate Injection — a sterile, clear, colourless, preservative-free aqueous solution of caffeine citrate, a methylxanthine central-nervous-system and respiratory stimulant, supplied commonly as 20 mg/mL caffeine citrate (equivalent to 10 mg/mL caffeine base) in a 60 mg/3 mL single-dose vial for intravenous infusion (and oral use) — is the standard hospital agent for the treatment of apnoea of prematurity in neonates. Because the pat

Last Updated: June 17, 2026 TL;DR: Promethazine HCl Injection — a sterile, clear, colourless to very faintly coloured aqueous solution of promethazine hydrochloride, a phenothiazine-derivative first-generation H1 antihistamine with marked antiemetic, sedative and anticholinergic properties, supplied commonly as a 25 mg/mL ampoule (also 50 mg/mL) for deep intramuscular use and, with caution, slow intravenous use — is a versatile hospital agent for nausea and vomiting, allergic

Last Updated: June 16, 2026 TL;DR: Ramosetron HCl Injection — a sterile, clear, colourless aqueous solution of ramosetron hydrochloride, a potent, long-acting second-generation selective 5-HT3 (serotonin) receptor antagonist antiemetic, supplied commonly as a 0.3 mg/2 mL ampoule or vial for intravenous use — is a hospital agent for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) and post-operative nausea and vomiting (PONV). Because the dose is

Last Updated: June 16, 2026 TL;DR: Hyoscine Butylbromide Injection — a sterile, clear, colourless aqueous solution of hyoscine butylbromide (scopolamine butylbromide), a quaternary ammonium antimuscarinic antispasmodic, supplied commonly as a 20 mg/1 mL ampoule for intramuscular or intravenous use — is a frontline hospital agent for the rapid relief of acute smooth-muscle spasm of the gastrointestinal, biliary and genitourinary tracts, including the colic of renal and biliary

Last Updated: June 15, 2026 TL;DR: Granisetron HCl Injection — a sterile, clear, colourless aqueous solution of granisetron hydrochloride, a selective 5-HT3 (serotonin) receptor antagonist antiemetic, supplied commonly as a 1 mg/mL ampoule and a 3 mg/3 mL vial for intravenous use — is a frontline hospital agent for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting (

Last Updated: June 15, 2026 TL;DR: Sugammadex Sodium Injection — a sterile, clear, colourless to slightly yellow-brown aqueous solution of sugammadex sodium, a selective relaxant binding agent (a modified gamma-cyclodextrin), supplied commonly as a 200 mg/2 mL vial and a 500 mg/5 mL vial (100 mg/mL) for single intravenous bolus injection — is the anaesthesia agent clinicians use to rapidly reverse rocuronium- or vecuronium-induced neuromuscular blockade, restoring normal musc